Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway

Lin Zhu,1 Jiawen Yang,1 Fengmei Li,2 Dandan Wang,1 Wenda Zhang,1 Jingmin Zhang,1 Zhenfeng Duan,3 Youhong Hu,1 Yubing Zhou,11Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of China; 2Department of Obstetrics and Gynecology,...

Descripción completa

Detalles Bibliográficos

Autores principales:	Zhu L, Yang J, Li F, Wang D, Zhang W, Zhang J, Duan Z, Hu Y, Zhou Y
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Dove Medical Press 2026-07-01
Colección:	Drug Design, Development and Therapy
Materias:	Metformin CDK4/6 inhibitor Palbociclib HR+/HER2- breast cancer PI3K/AKT/mTOR pathway
Acceso en línea:	https://www.dovepress.com/metformin-sensitizes-hrher2--breast-cancer-cells-to-cdk46-inhibitor-vi-peer-reviewed-fulltext-article-DDDT
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!